CD9

Last updated
Crystal structure of human CD9 Crystal structure of human CD9.pdf
Crystal structure of human CD9
CD9
Identifiers
Aliases CD9 , BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29, CD9 molecule
External IDs OMIM: 143030 MGI: 88348 HomoloGene: 20420 GeneCards: CD9
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001769
NM_001330312

NM_007657

RefSeq (protein)

NP_001317241
NP_001760

NP_031683

Location (UCSC) Chr 12: 6.2 – 6.24 Mb Chr 6: 125.44 – 125.47 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

CD9 is a gene encoding a protein that is a member of the transmembrane 4 superfamily also known as the tetraspanin family. It is a cell surface glycoprotein that consists of four transmembrane regions and has two extracellular loops that contain disulfide bonds which are conserved throughout the tetraspanin family. [5] [6] [7] Also containing distinct palmitoylation sites that allows CD9 to interact with lipids and other proteins. [5] [8] [9]

Contents

Function

Tetraspanin proteins are involved in a multitude of biological processes such as adhesion, motility, membrane fusion, signaling and protein trafficking. [5] [10] Tetraspanins play a role in many biological processes because of their ability to interact with many different proteins including interactions between each other. Their distinct palmitoylation sites allow them to organize on the membrane into tetraspanin-enriched microdomains (TEM). [11] [8] [10] These TEMs are thought to play a role in many cellular processes including exosome biogenesis. [12] CD9 is commonly used as a marker for exosomes as it is contained on their surface. [11] [10] [13] [14]

However, in some cases CD9 plays a larger role in the ability of exosomes to be more or less pathogenic. Shown in HIV-1 infection, exosomes are able to enhance HIV-1 entry through tetraspanin CD9 and CD81. [15] However, expression of CD9 on the cellular membrane seems to decrease the viral entry of HIV-1. [16] [17]

CD9 has a diverse role in cellular processes as it has also been shown to trigger platelet activation and aggregation. [18] It forms a alphaIIbbeta3-CD9-CD63 complex on the surface of platelets that interacts directly with other cells such as neutrophils which may assist in immune response. [11] [19] In addition, the protein appears to promote muscle cell fusion and support myotube maintenance. [20] [21] Also, playing a key role in egg-sperm fusion during mammalian fertilization. [9] While oocytes are ovulated, CD9-deficient oocytes do not properly fuse with sperm upon fertilization. [22] CD9 is located in the microvillar membrane of the oocytes and also appears to intervene in maintaining the normal shape of oocyte microvilli. [23]

CD9 can also modulate cell adhesion [24] and migration. [25] [26] This function makes CD9 of interest when studying cancer and cancer metastasis. However, it seems CD9 has a varying role in different types of cancers. Studies showed that CD9 expression levels have an inverse correlation to metastatic potential or patient survival. The over expression of CD9 was shown to decrease metastasis in certain types of melanoma, breast, lung, pancreas and colon carcinomas. [27] [28] [29] [30] [31] However in other studies, CD9 has been shown to increase migration or be highly expressed in metastatic cancers in various cell lines such as lung cancer, [25] scirrhous-type gastric cancer, [26] hepatocellular carcinoma, [32] acute lymphoblastic leukemia, [33] and breast cancer. Suggesting based on the cancer CD9 can be a tumor suppressor or promotor. [34] It has also been suggested that CD9 has an effect on the ability for cancer cells to develop chemoresistance.

Additionally, CD9 has been shown to block adhesion of Staphylococcus aureus to wounds. The adhesion is essential for infection of the wound. [35] This suggests that CD9 could be of possible use to as treatment for skin infection by Staphylococcus aureus.

Interactions

CD9 has been shown to interact with:

See also

Related Research Articles

<span class="mw-page-title-main">Cell adhesion</span> Process of cell attachment

Cell adhesion is the process by which cells interact and attach to neighbouring cells through specialised molecules of the cell surface. This process can occur either through direct contact between cell surfaces such as cell junctions or indirect interaction, where cells attach to surrounding extracellular matrix, a gel-like structure containing molecules released by cells into spaces between them. Cells adhesion occurs from the interactions between cell-adhesion molecules (CAMs), transmembrane proteins located on the cell surface. Cell adhesion links cells in different ways and can be involved in signal transduction for cells to detect and respond to changes in the surroundings. Other cellular processes regulated by cell adhesion include cell migration and tissue development in multicellular organisms. Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. Cell adhesion is also essential for infectious organisms, such as bacteria or viruses, to cause diseases.

<span class="mw-page-title-main">Integrin beta 1</span> Mammalian protein found in Homo sapiens

Integrin beta-1 (ITGB1), also known as CD29, is a cell surface receptor that in humans is encoded by the ITGB1 gene. This integrin associates with integrin alpha 1 and integrin alpha 2 to form integrin complexes which function as collagen receptors. It also forms dimers with integrin alpha 3 to form integrin receptors for netrin 1 and reelin. These and other integrin beta 1 complexes have been historically known as very late activation (VLA) antigens.

<span class="mw-page-title-main">Integrin alpha 4</span>

CD49d is an integrin alpha subunit. It makes up half of the α4β1 lymphocyte homing receptor.

<span class="mw-page-title-main">CD37</span> Mammalian protein found in Homo sapiens

Leukocyte antigen CD37 is a protein that in humans is encoded by the CD37 gene.

<span class="mw-page-title-main">CD53</span> Mammalian protein found in Homo sapiens

Leukocyte surface antigen CD53 is a protein that in humans is encoded by the CD53 gene.

<span class="mw-page-title-main">CD63</span>

CD63 antigen is a protein that, in humans, is encoded by the CD63 gene. CD63 is mainly associated with membranes of intracellular vesicles, although cell surface expression may be induced.

<span class="mw-page-title-main">CD151</span> Protein-coding gene in the species Homo sapiens

CD151 molecule, also known as CD151, is a human gene.

<span class="mw-page-title-main">GPR56</span> Protein-coding gene in the species Homo sapiens

G protein-coupled receptor 56 also known as TM7XN1 is a protein encoded by the ADGRG1 gene. GPR56 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.

<span class="mw-page-title-main">CD81</span>

CD81 molecule, also known as CD81, is a protein which in humans is encoded by the CD81 gene. It is also known as 26 kDa cell surface protein, TAPA-1, and Tetraspanin-28 (Tspan-28).

<span class="mw-page-title-main">CD47</span> Protein-coding gene in humans

CD47 also known as integrin associated protein (IAP) is a transmembrane protein that in humans is encoded by the CD47 gene. CD47 belongs to the immunoglobulin superfamily and partners with membrane integrins and also binds the ligands thrombospondin-1 (TSP-1) and signal-regulatory protein alpha (SIRPα). CD-47 acts as a don't eat me signal to macrophages of the immune system which has made it a potential therapeutic target in some cancers, and more recently, for the treatment of pulmonary fibrosis.

<i>CD82</i> (gene) Mammalian protein found in Homo sapiens

CD82, or KAI1, is a human protein encoded by the CD82 gene.

<span class="mw-page-title-main">TSPAN7</span> Protein-coding gene in humans

Tetraspanin-7 is a protein that in humans is encoded by the TSPAN7 gene.

<span class="mw-page-title-main">CDCP1</span> Protein-coding gene in the species Homo sapiens

CUB domain-containing protein 1 (CDCP1) is a protein that in humans is encoded by the CDCP1 gene. CDCP1 has also been designated as CD318 and Trask. Alternatively spliced transcript variants encoding distinct isoforms have been reported.

<span class="mw-page-title-main">Uroplakin-1a</span> Mammalian protein found in Homo sapiens

Uroplakin-1a (UP1a) is a protein that in humans is encoded by the UPK1A gene.

<span class="mw-page-title-main">TSPAN13</span> Protein-coding gene in humans

Tetraspanin-13 is a protein that in humans is encoded by the TSPAN13 gene.

<span class="mw-page-title-main">TSPAN4</span> Protein-coding gene in humans

Tetraspanin-4 is a protein that in humans is encoded by the TSPAN4 gene.

<span class="mw-page-title-main">PTGFRN</span> Protein-coding gene in the species Homo sapiens

Prostaglandin F2 receptor negative regulator is a protein that in humans is encoded by the PTGFRN gene. PTGFRN has also been designated as CD315.

<span class="mw-page-title-main">TSPAN8</span> Protein-coding gene in humans

Tetraspanin-8 is a protein that in humans is encoded by the TSPAN8 gene.

<span class="mw-page-title-main">TM4SF5</span> Protein-coding gene in the species Homo sapiens

Transmembrane 4 L6 family member 5 is a protein that in humans is encoded by the TM4SF5 gene.

<span class="mw-page-title-main">TSPAN12</span> Protein-coding gene in humans

Tetraspanin-12 (Tspan-12) also known as tetraspan NET-2 (NET2) or transmembrane 4 superfamily member 12 (TM4SF12) is a tetraspanin protein that in humans is encoded by the TSPAN12 gene. Tetraspanin-12 is found in the membrane of a variety of cells. It has an unusually long C-terminal intracellular tail of approximately 60 amino acids.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000010278 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000030342 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 Andreu Z, Yáñez-Mó M (2014). "Tetraspanins in extracellular vesicle formation and function". Frontiers in Immunology. 8: 342. doi: 10.3389/fimmu.2014.00442 . PMC   4165315 . PMID   25278937.
  6. "CD9 CD9 molecule [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2019-12-04.
  7. "CD9 Gene - GeneCards | CD9 Protein | CD9 Antibody". www.genecards.org. Retrieved 2019-12-04.
  8. 1 2 Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F (September 2009). "Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes". Trends in Cell Biology. 19 (9): 434–46. doi:10.1016/j.tcb.2009.06.004. PMID   19709882.
  9. 1 2 Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, Strominger JL, Hemler ME (May 2006). "Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization". The Journal of Biological Chemistry. 281 (18): 12976–85. doi: 10.1074/jbc.M510617200 . PMID   16537545.
  10. 1 2 3 Hemler ME (October 2005). "Tetraspanin functions and associated microdomains". Nature Reviews. Molecular Cell Biology. 6 (10): 801–11. doi:10.1038/nrm1736. PMID   16314869. S2CID   5906694.
  11. 1 2 3 4 Israels SJ, McMillan-Ward EM, Easton J, Robertson C, McNicol A (January 2001). "CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets". Thrombosis and Haemostasis. 85 (1): 134–41. doi:10.1055/s-0037-1612916. PMID   11204565. S2CID   28721583.
  12. Perez-Hernandez D, Gutiérrez-Vázquez C, Jorge I, López-Martín S, Ursa A, Sánchez-Madrid F, et al. (April 2013). "The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes". The Journal of Biological Chemistry. 288 (17): 11649–61. doi: 10.1074/jbc.M112.445304 . PMC   3636856 . PMID   23463506.
  13. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. (May 2010). "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury". Stem Cell Research. 4 (3): 214–22. doi: 10.1016/j.scr.2009.12.003 . PMID   20138817.
  14. Sumiyoshi N, Ishitobi H, Miyaki S, Miyado K, Adachi N, Ochi M (October 2016). "The role of tetraspanin CD9 in osteoarthritis using three different mouse models". Biomedical Research. 37 (5): 283–291. doi: 10.2220/biomedres.37.283 . PMID   27784871.
  15. Sims B, Farrow AL, Williams SD, Bansal A, Krendelchtchikov A, Matthews QL (June 2018). "Tetraspanin blockage reduces exosome-mediated HIV-1 entry". Archives of Virology. 163 (6): 1683–1689. doi:10.1007/s00705-018-3737-6. PMC   5958159 . PMID   29429034.
  16. Gordón-Alonso M, Yañez-Mó M, Barreiro O, Alvarez S, Muñoz-Fernández MA, Valenzuela-Fernández A, Sánchez-Madrid F (October 2006). "Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion". Journal of Immunology. 177 (8): 5129–37. doi: 10.4049/jimmunol.177.8.5129 . PMID   17015697.
  17. Thali M (2009). "The roles of tetraspanins in HIV-1 replication". HIV Interactions with Host Cell Proteins. Current Topics in Microbiology and Immunology. Vol. 339. Springer Berlin Heidelberg. pp. 85–102. doi:10.1007/978-3-642-02175-6_5. ISBN   978-3-642-02174-9. PMC   4067973 . PMID   20012525.
  18. Rubinstein E, Billard M, Plaisance S, Prenant M, Boucheix C (September 1993). "Molecular cloning of the mouse equivalent of CD9 antigen". Thrombosis Research. 71 (5): 377–83. doi:10.1016/0049-3848(93)90162-h. PMID   8236164.
  19. Yun SH, Sim EH, Goh RY, Park JI, Han JY (2016). "Platelet Activation: The Mechanisms and Potential Biomarkers". BioMed Research International. 2016: 9060143. doi: 10.1155/2016/9060143 . PMC   4925965 . PMID   27403440.
  20. Tachibana I, Hemler ME (August 1999). "Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance". The Journal of Cell Biology. 146 (4): 893–904. doi:10.1083/jcb.146.4.893. PMC   2156130 . PMID   10459022.
  21. Charrin S, Latil M, Soave S, Polesskaya A, Chrétien F, Boucheix C, Rubinstein E (2013). "Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81". Nature Communications. 4: 1674. Bibcode:2013NatCo...4.1674C. doi: 10.1038/ncomms2675 . PMID   23575678.
  22. Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C (January 2000). "Severely reduced female fertility in CD9-deficient mice". Science. 287 (5451): 319–21. Bibcode:2000Sci...287..319L. doi:10.1126/science.287.5451.319. PMID   10634790.
  23. Runge KE, Evans JE, He ZY, Gupta S, McDonald KL, Stahlberg H, et al. (April 2007). "Oocyte CD9 is enriched on the microvillar membrane and required for normal microvillar shape and distribution". Developmental Biology. 304 (1): 317–25. doi:10.1016/j.ydbio.2006.12.041. PMID   17239847.
  24. Machado-Pineda Y, Cardeñes B, Reyes R, López-Martín S, Toribio V, Sánchez-Organero P, et al. (2018). "CD9 Controls Integrin α5β1-Mediated Cell Adhesion by Modulating Its Association With the Metalloproteinase ADAM17". Frontiers in Immunology. 9: 2474. doi: 10.3389/fimmu.2018.02474 . PMC   6230984 . PMID   30455686.
  25. 1 2 Blake DJ, Martiszus JD, Lone TH, Fenster SD (November 2018). "Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16". Cytokine. 111: 567–570. doi:10.1016/j.cyto.2018.05.038. PMC   8711597 . PMID   29884309. S2CID   46997236.
  26. 1 2 Miki Y, Yashiro M, Okuno T, Kitayama K, Masuda G, Hirakawa K, Ohira M (March 2018). "CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells". British Journal of Cancer. 118 (6): 867–877. doi:10.1038/bjc.2017.487. PMC   5886122 . PMID   29438363.
  27. Mimori K, Mori M, Shiraishi T, Tanaka S, Haraguchi M, Ueo H, et al. (March 1998). "Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours". International Journal of Oncology. 12 (3): 597–601. doi:10.3892/ijo.12.3.597. PMID   9472098.
  28. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, et al. (December 1995). "Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer". Cancer Research. 55 (24): 6040–4. doi:10.1016/0169-5002(96)87780-4. PMID   8521390.
  29. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M (May 1993). "Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA". The Journal of Experimental Medicine. 177 (5): 1231–7. doi:10.1084/jem.177.5.1231. PMC   2191011 . PMID   8478605.
  30. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, et al. (October 1998). "Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer". International Journal of Cancer. 79 (5): 509–16. doi:10.1002/(sici)1097-0215(19981023)79:5<509::aid-ijc11>3.0.co;2-x. PMID   9761121. S2CID   19842716.
  31. Ovalle S, Gutiérrez-López MD, Olmo N, Turnay J, Lizarbe MA, Majano P, et al. (November 2007). "The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells". International Journal of Cancer. 121 (10): 2140–52. doi: 10.1002/ijc.22902 . PMID   17582603. S2CID   22410504.
  32. Lin Q, Peng S, Yang Y (July 2018). "Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H". International Journal of Oncology. 53 (1): 266–274. doi: 10.3892/ijo.2018.4381 . PMID   29749468.
  33. Liang P, Miao M, Liu Z, Wang H, Jiang W, Ma S, et al. (2018). "CD9 expression indicates a poor outcome in acute lymphoblastic leukemia". Cancer Biomarkers. 21 (4): 781–786. doi:10.3233/CBM-170422. PMID   29286918.
  34. Zöller M (January 2009). "Tetraspanins: push and pull in suppressing and promoting metastasis". Nature Reviews. Cancer. 9 (1): 40–55. doi:10.1038/nrc2543. PMID   19078974. S2CID   32065330.
  35. Ventress JK, Partridge LJ, Read RC, Cozens D, MacNeil S, Monk PN (2016-07-28). "Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes". PLOS ONE. 11 (7): e0160387. Bibcode:2016PLoSO..1160387V. doi: 10.1371/journal.pone.0160387 . PMC   4965146 . PMID   27467693.
  36. Anzai N, Lee Y, Youn BS, Fukuda S, Kim YJ, Mantel C, et al. (June 2002). "C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors". Blood. 99 (12): 4413–21. doi:10.1182/blood.v99.12.4413. PMID   12036870.
  37. 1 2 Radford KJ, Thorne RF, Hersey P (May 1996). "CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma". Biochemical and Biophysical Research Communications. 222 (1): 13–8. doi:10.1006/bbrc.1996.0690. PMID   8630057.
  38. Mazzocca A, Carloni V, Sciammetta S, Cordella C, Pantaleo P, Caldini A, et al. (September 2002). "Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration". Journal of Hepatology. 37 (3): 322–30. doi:10.1016/s0168-8278(02)00175-7. PMID   12175627.
  39. Lozahic S, Christiansen D, Manié S, Gerlier D, Billard M, Boucheix C, Rubinstein E (March 2000). "CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans". European Journal of Immunology. 30 (3): 900–7. doi: 10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X . PMID   10741407.
  40. Park KR, Inoue T, Ueda M, Hirano T, Higuchi T, Maeda M, et al. (March 2000). "CD9 is expressed on human endometrial epithelial cells in association with integrins alpha(6), alpha(3) and beta(1)". Molecular Human Reproduction. 6 (3): 252–7. doi: 10.1093/molehr/6.3.252 . PMID   10694273.
  41. Hirano T, Higuchi T, Ueda M, Inoue T, Kataoka N, Maeda M, et al. (February 1999). "CD9 is expressed in extravillous trophoblasts in association with integrin alpha3 and integrin alpha5". Molecular Human Reproduction. 5 (2): 162–7. doi: 10.1093/molehr/5.2.162 . PMID   10065872.
  42. Horváth G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E (November 1998). "CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82". The Journal of Biological Chemistry. 273 (46): 30537–43. doi: 10.1074/jbc.273.46.30537 . PMID   9804823.
  43. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, et al. (April 2001). "The major CD9 and CD81 molecular partner. Identification and characterization of the complexes". The Journal of Biological Chemistry. 276 (17): 14329–37. doi: 10.1074/jbc.M011297200 . PMID   11278880.
  44. Stipp CS, Orlicky D, Hemler ME (February 2001). "FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein". The Journal of Biological Chemistry. 276 (7): 4853–62. doi: 10.1074/jbc.M009859200 . PMID   11087758.
  45. Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME (November 1997). "NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins". The Journal of Biological Chemistry. 272 (46): 29181–9. doi: 10.1074/jbc.272.46.29181 . PMID   9360996.
  46. Gutiérrez-López MD, Gilsanz A, Yáñez-Mó M, Ovalle S, Lafuente EM, Domínguez C, et al. (October 2011). "The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9". Cellular and Molecular Life Sciences. 68 (19): 3275–92. doi:10.1007/s00018-011-0639-0. PMID   21365281. S2CID   23682577.
  47. Gustafson-Wagner E, Stipp CS (2013). "The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms". PLOS ONE. 8 (4): e61834. Bibcode:2013PLoSO...861834G. doi: 10.1371/journal.pone.0061834 . PMC   3629153 . PMID   23613949.

Further reading